The Biochemical journal

For a PDK1 inhibitor, the substrate matters.

For a PDK1 inhibitor, the substrate matters.

Development of antibody fragments for immunotherapy of prion diseases.

Development of antibody fragments for immunotherapy of prion diseases.

A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition.

PKCbetaII modulates translation independently from mTOR and through RACK1.

PKCbetaII modulates translation independently from mTOR and through RACK1.

A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition.

Prion liposomes.

Prion liposomes.